|Articles|May 15, 2002
Third party quiet: LaserSight licenses AstraMax Technology
Winter Park, FL-LaserSight Inc. and an undisclosed third party have entered into a nonexclusive deal to license LaserSight's AstraMax technology for $5 million.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Metformin use associated with reduced incidence of intermediate AMD
2
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio
3
Looking back at the 2025 EnVision Summit
4
Last year in glaucoma at EnVision Summit 2025
5
























